Medipharm Labs Corp T.LABS

Under the radar progress.

[alleyesonme]

April 2024, entered a GMP flower and extract agreement with Pharmadrug Production GmBH, for the U.K and German markets...July 2024 entered a product development and manufacturing agreement with Avextra pharma GMBH for a novel cannabis product and delivery method. Avextras proprietary product will be distributed in international medical cannabis markets...additionally in July began delivering high potency flower to German distributor partners branded beacon medical... each one of these items warrants its own P/R. I'v been examining financials on large cannabis corps like canopy, Aurora, curaleaf, Verrano, Tilray....I can't stomach an investment in any of them...debt/burn rate, places them in a dangerously precarious situation...as frustrating as it is with this SP, I know my moneys in the right place. https://docs.publicnow.com/viewDoc?filename=179942%5CEXT%5C06EB3DE1B53621923B3ECD3C59BADD77A257CD20_4B5D1297903FBB4F1FB3423E7AD83B32FD472F68.PDF

[QContinuum1]

These are nice things to know, but I disagree that they are not themselves worthy of news releases. They've publicized much in the past about partner x or y, but in the end, those partnerships mean nothing if they don't generate sales or come with purchase orders.  So unless Pharmadrug or Avextra signed a contract for guaranteed pull-through, then the agreements don't mean

[Solid1]

It is not unusual for various pharma partners to hold back for the time being and for there to be no information - the market for cannabis has not been regulated for years and the whole thing has only got rolling in the last few months. For example, the legal changes in Germany or the fact that the DEA has approved the FDA's two-stage evaluation for cannabis medicines - as long as it is not